What is the immediate antidotal treatment for a calcium‑channel‑blocker overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antidote for Calcium Channel Blocker Overdose

For immediate antidotal treatment of calcium channel blocker overdose, administer IV calcium as the first-line antidote, followed immediately by high-dose insulin euglycemia therapy (HIET), with vasopressors (norepinephrine/epinephrine) for hemodynamic support. 1, 2

First-Line Antidotal Therapies (Initiate Simultaneously)

IV Calcium

  • Administer 0.3 mEq/kg (0.6 mL/kg of 10% calcium gluconate OR 0.2 mL/kg of 10% calcium chloride) IV over 5-10 minutes 2
  • Follow with continuous infusion of 0.3 mEq/kg per hour, titrated to hemodynamic response 2
  • Target ionized calcium levels up to twice normal, but avoid severe hypercalcemia (>2× upper limit) 1, 2
  • While calcium is recommended first-line, most patients require additional treatments beyond calcium monotherapy 1

High-Dose Insulin Euglycemia Therapy (HIET)

  • Initiate early—HIET is most effective when started in the intoxication phase, even before significant hemodynamic instability develops 3
  • Give 1 U/kg regular insulin IV bolus with 0.5 g/kg dextrose 2
  • Start continuous infusion at 0.5-1 U/kg/hr insulin with 0.5 g/kg/hr dextrose 2
  • Titrate insulin incrementally up to 10 U/kg/hr based on clinical response 1, 2
  • Monitor glucose every 15 minutes initially, then hourly once stable; maintain glucose 100-250 mg/dL 2
  • Monitor potassium every 1-2 hours and supplement as needed (insulin drives potassium intracellularly) 2
  • HIET improves cardiac inotropy, facilitates myocardial carbohydrate utilization, and has shown favorable outcomes with lower vasoconstrictive complications than vasopressor-only therapy 1

Vasopressor Support

  • Norepinephrine and/or epinephrine are recommended first-line for hemodynamic support 1
  • Large retrospective series demonstrate excellent survival with vasopressors (norepinephrine up to 100 μg/min in adults) with low ischemic complication rates 1
  • Consider dobutamine or epinephrine specifically for cardiogenic shock 1
  • Atropine may be attempted for symptomatic bradycardia but has limited efficacy 1

Second-Line Therapies for Refractory Cases

Escalate HIET

  • Increase insulin infusion incrementally up to 10 U/kg/hr if myocardial dysfunction persists 1, 2
  • Continue aggressive dextrose supplementation to maintain euglycemia 1

Intravenous Lipid Emulsion (ILE)

  • The 2023 American Heart Association guidelines recommend AGAINST routine use of ILE for CCB poisoning 1
  • Reserve ILE only for refractory shock or periarrest states unresponsive to other therapies 1, 2
  • Evidence shows ILE may increase gastrointestinal absorption of oral CCB overdoses, potentially worsening toxicity 1
  • If used: 1.5 mL/kg of 20% lipid emulsion bolus, repeat up to twice, followed by 0.25 mL/kg/min infusion for 30-60 minutes 1
  • Maximum dose: 12.5 mL/kg per 24 hours 1

Temporary Cardiac Pacing

  • Consider for unstable bradycardia or high-grade AV block WITHOUT significant myocardial dysfunction 1, 2
  • Try transcutaneous pacing first; if effective, proceed to transvenous pacing 1
  • Results are mixed—pacing may not be effective in complete AV nodal blockade or vasodilatory shock 1

Glucagon

  • Evidence for glucagon is inconsistent with variable response rates 1, 3
  • Vomiting is common and rapid tachyphylaxis may occur 1
  • The 2023 AHA guidelines state the usefulness is uncertain 1

Rescue Therapies for Refractory Shock/Periarrest

VA-ECMO (Venoarterial Extracorporeal Membrane Oxygenation)

  • Strongly consider VA-ECMO for refractory cardiogenic shock unresponsive to maximal pharmacologic therapy 1, 2
  • Case series report survival rates as high as 77% with VA-ECMO in CCB overdose 1
  • VA-ECMO is particularly effective when pump failure (cardiogenic component) predominates 1, 2

Cardiac Arrest Management

  • Administer IV calcium bolus in addition to standard ACLS protocols 1, 2
  • Give IV lipid emulsion therapy during cardiac arrest 1, 2
  • Deploy VA-ECMO if available 1, 2

Critical Monitoring Parameters

  • Continuous cardiac telemetry for rhythm and conduction abnormalities 2
  • Arterial line for continuous blood pressure monitoring in shock states 2
  • Serum glucose every 15 minutes during HIET titration, then hourly 2
  • Serum potassium every 1-2 hours during HIET 2
  • Ionized calcium levels during calcium infusions 2

Common Pitfalls to Avoid

  • Do not delay HIET initiation—it is most effective when started early, even before severe hemodynamic compromise 3
  • Do not use ILE routinely—reserve for refractory cases only, as it may worsen oral overdoses 1
  • Do not rely on calcium monotherapy alone—most patients require multimodal therapy 1
  • Do not attempt electrical pacing in patients with significant myocardial dysfunction—it will likely be ineffective 1
  • Avoid hypoglycemia during HIET by maintaining aggressive glucose monitoring and dextrose supplementation 2
  • Watch for hypokalemia and volume overload during HIET 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Calcium Channel Blocker Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Practical recommendations for calcium channel antagonist poisoning.

The Netherlands journal of medicine, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.